Skip to main content

Advertisement

Springer Nature Link
Log in

Critical Care Management in Cirrhosis

  • Management of the Cirrhotic Patient (NS Reau and A Cardenas, Section Editors)
  • Published:
Current Hepatology Reports Aims and scope Submit manuscript

Abstract

The critical care management of cirrhotic patients involves a multidisciplinary team approach, including the hepatologist and intensivist, to address life-threatening complications and to provide comprehensive care for multi-organ failure commonly seen in these patients. A systematic approach to the diagnosis and therapy of multi-organ system dysfunction is essential to optimize the intensive care management of these complex patients, with a goal to stabilize them for possible liver transplantation. This review provides a system-based approach for the intensive care management of critically ill cirrhotic patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

AMS:

Altered mental status

HE:

Hepatic encephalopathy

SBP:

Spontaneous bacterial peritonitis

HRS:

Hepatorenal syndrome

HPS:

Hepatopulmonary syndrome

PPH:

Portopulmonary hypertension

ACLF:

Acute on chronic renal failure

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Olson JC et al. Intensive care of the patient with cirrhosis. Hepatology. 2011;54(5):1864–72.

    Article  PubMed  Google Scholar 

  2. Karvellas CJ, Bagshaw SM. Advances in management and prognostication in critically ill cirrhotic patients. Curr Opin Crit Care. 2014;20(2):210–7.

    Article  PubMed  Google Scholar 

  3. Gines P et al. Management of critically-ill cirrhotic patients. J Hepatol. 2012;56 Suppl 1:S13–24.

    Article  CAS  PubMed  Google Scholar 

  4. Ford RM, Sakaria SS, Subramanian RM. Critical care management of patients before liver transplantation. Transplant Rev (Orlando). 2010;24(4):190–206.

    Article  Google Scholar 

  5. Mullen KD et al. Rifaximin is safe and well tolerated for long-term maintenance of remission from overt hepatic encephalopathy. Clin Gastroenterol Hepatol. 2014;12(8):1390–1397 e2.

    Article  CAS  PubMed  Google Scholar 

  6. Bass NM et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med. 2010;362(12):1071–81.

    Article  CAS  PubMed  Google Scholar 

  7. Mas A et al. Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial. J Hepatol. 2003;38(1):51–8.

    Article  CAS  PubMed  Google Scholar 

  8. Hassanein TI et al. Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology. 2007;46(6):1853–62.

    Article  CAS  PubMed  Google Scholar 

  9. Laleman W et al. Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: a multicenter survey on safety and efficacy. Hepatology. 2013;57(6):2448–57.

    Article  PubMed  Google Scholar 

  10. Garcia-Tsao G et al. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology. 1985;5(3):419–24.

    Article  CAS  PubMed  Google Scholar 

  11. Carbonell N et al. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology. 2004;40(3):652–9.

    Article  PubMed  Google Scholar 

  12. Villanueva C et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368(1):11–21.

    Article  CAS  PubMed  Google Scholar 

  13. Bosch J et al. Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: a randomized, controlled trial. Hepatology. 2008;47(5):1604–14.

    Article  CAS  PubMed  Google Scholar 

  14. Theivanayagam S et al. Administration of erythromycin before endoscopy in upper gastrointestinal bleeding: a meta-analysis of randomized controlled trials. Saudi J Gastroenterol. 2013;19(5):205–10.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Levacher S et al. Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet. 1995;346(8979):865–8.

    Article  CAS  PubMed  Google Scholar 

  16. Bernard B et al. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology. 1999;29(6):1655–61.

    Article  CAS  PubMed  Google Scholar 

  17. Soares-Weiser K et al. Antibiotic prophylaxis of bacterial infections in cirrhotic inpatients: a meta-analysis of randomized controlled trials. Scand J Gastroenterol. 2003;38(2):193–200.

    Article  CAS  PubMed  Google Scholar 

  18. Garcia-Tsao G et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46(3):922–38.

    Article  CAS  PubMed  Google Scholar 

  19. Shaheen NJ et al. Pantoprazole reduces the size of postbanding ulcers after variceal band ligation: a randomized, controlled trial. Hepatology. 2005;41(3):588–94.

    Article  CAS  PubMed  Google Scholar 

  20. Boo GB et al. The effect of proton pump inhibitor on healing of post-esophageal variceal ligation ulcers. Korean J Gastroenterol. 2008;51(4):232–40.

    PubMed  Google Scholar 

  21. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2005;43(1):167–76.

    Article  PubMed  Google Scholar 

  22. Romero-Castro R et al. EUS-guided coil versus cyanoacrylate therapy for the treatment of gastric varices: a multicenter study (with videos). Gastrointest Endosc. 2013;78(5):711–21.

    Article  PubMed  Google Scholar 

  23. Procaccini NJ et al. Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center U.S. analysis. Gastrointest Endosc. 2009;70(5):881–7.

    Article  PubMed  Google Scholar 

  24. Crisan D, Tantau M, Tantau A. Endoscopic management of bleeding gastric varices—an updated overview. Curr Gastroenterol Rep. 2014;16(10):413.

    Article  PubMed  Google Scholar 

  25. Garcia-Pagan JC et al. Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study. J Hepatol. 2013;58(1):45–50.

    Article  PubMed  Google Scholar 

  26. Garcia-Pagan JC et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010;362(25):2370–9.

    Article  CAS  PubMed  Google Scholar 

  27. Runyon BA, Committee APG. Management of adult patients with ascites due to cirrhosis: an update. Hepatology. 2009;49(6):2087–107.

    Article  PubMed  Google Scholar 

  28. Such J, Runyon BA. Spontaneous bacterial peritonitis. Clin Infect Dis. 1998;27(4):669–74. quiz 675–6.

    Article  CAS  PubMed  Google Scholar 

  29. Pleguezuelo M et al. Diagnosis and management of bacterial infections in decompensated cirrhosis. World J Hepatol. 2013;5(1):16–25.

    Article  PubMed Central  PubMed  Google Scholar 

  30. Bellot P et al. Automated low flow pump system for the treatment of refractory ascites: a multi-center safety and efficacy study. J Hepatol. 2013;58(5):922–7.

    Article  PubMed  Google Scholar 

  31. Kwon JH et al. Mortality associated with proton pump inhibitors in cirrhotic patients with spontaneous bacterial peritonitis. J Gastroenterol Hepatol. 2014;29(4):775–81.

    Article  CAS  PubMed  Google Scholar 

  32. Serste T et al. Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. Hepatology. 2010;52(3):1017–22.

    Article  CAS  PubMed  Google Scholar 

  33. Mandorfer M et al. Nonselective beta blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis. Gastroenterology. 2014;146(7):1680–90 e1.

    Article  CAS  PubMed  Google Scholar 

  34. Gustot T et al. Severe sepsis in cirrhosis. Hepatology. 2009;50(6):2022–33.

    Article  CAS  PubMed  Google Scholar 

  35. Karvellas CJ et al. Bacteremia, acute physiology and chronic health evaluation II and modified end stage liver disease are independent predictors of mortality in critically ill nontransplanted patients with acute on chronic liver failure. Crit Care Med. 2010;38(1):121–6.

    Article  PubMed  Google Scholar 

  36. Bajaj JS et al. Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience. Hepatology. 2012;56(6):2328–35. Prospective cohort study showed potentially preventable second infections are predictors of mortality independent of severity of cirrhosis.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  37. Monnet X, Teboul J-L. Prediction of fluid responsiveness in patients with shock. Clin Pulm Med. 2014;21(6):282–7.

    Article  Google Scholar 

  38. Rivers E et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368–77.

    Article  CAS  PubMed  Google Scholar 

  39. Early Goal-Directed Therapy Collaborative Group of Zhejiang, P. The effect of early goal-directed therapy on treatment of critical patients with severe sepsis/septic shock: a multi-center, prospective, randomized, controlled study. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2010;22(6):331–4.

  40. Moreau R et al. Abnormal tissue oxygenation in patients with cirrhosis and liver failure. J Hepatol. 1988;7(1):98–105.

    Article  CAS  PubMed  Google Scholar 

  41. Dellinger RP et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580–637.

    Article  PubMed  Google Scholar 

  42. Arabi YM et al. Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis. Hepatology. 2012;56(6):2305–15.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  43. De Backer D et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362(9):779–89.

    Article  PubMed  Google Scholar 

  44. Acevedo J et al. Relative adrenal insufficiency in decompensated cirrhosis: relationship to short-term risk of severe sepsis, hepatorenal syndrome, and death. Hepatology. 2013;58(5):1757–65.

    Article  CAS  PubMed  Google Scholar 

  45. Moreau R et al. Septic shock in patients with cirrhosis: hemodynamic and metabolic characteristics and intensive care unit outcome. Crit Care Med. 1992;20(6):746–50.

    Article  CAS  PubMed  Google Scholar 

  46. Kor DJ, Gajic O. Blood product transfusion in the critical care setting. Curr Opin Crit Care. 2010;16(4):309–16.

    Article  PubMed  Google Scholar 

  47. Bianchini M, De Pietri L, Villa E. Coagulopathy in liver diseases: complication or therapy? Dig Dis. 2014;32(5):609–14.

    Article  PubMed  Google Scholar 

  48. Intagliata NM et al. Prophylactic anticoagulation for venous thromboembolism in hospitalized cirrhosis patients is not associated with high rates of gastrointestinal bleeding. Liver Int. 2014;34(1):26–32.

    Article  CAS  PubMed  Google Scholar 

  49. Yang ZJ et al. Venous thromboembolism in cirrhosis. Clin Appl Thromb Hemost. 2014;20(2):169–78.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  50. Levesque E et al. Outcome of patients with cirrhosis requiring mechanical ventilation in ICU. J Hepatol. 2014;60(3):570–8.

    Article  CAS  PubMed  Google Scholar 

  51. Machicao VI, Balakrishnan M, Fallon MB. Pulmonary complications in chronic liver disease. Hepatology. 2014;59(4):1627–37.

    Article  PubMed  Google Scholar 

  52. Sharma P, Rakela J. Management of pre-liver transplantation patient—part 2. Liver Transpl. 2005;11(3):249–60.

    Article  PubMed  Google Scholar 

  53. Ramsay MA. Portopulmonary hypertension and hepatopulmonary syndrome, and liver transplantation. Int Anesthesiol Clin. 2006;44(3):69–82.

    Article  PubMed  Google Scholar 

  54. Talwalkar JA et al. Prevalence of spontaneous portosystemic shunts in patients with portopulmonary hypertension and effect on treatment. Gastroenterology. 2011;141(5):1673–9.

    Article  PubMed  Google Scholar 

  55. Colle IO et al. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study. Hepatology. 2003;37(2):401–9.

    Article  PubMed  Google Scholar 

  56. Wong F et al. New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection. Gastroenterology. 2013;145(6):1280–8 e1. Consensus conference proposed definition for cirrhosis-associated acute kidney injury (AKI).

    Article  PubMed  Google Scholar 

  57. Barreto R et al. Type-1 hepatorenal syndrome associated with infections in cirrhosis: natural history, outcome of kidney function, and survival. Hepatology. 2014;59(4):1505–13. This prospective study shows two thirds of patients with HRS-1 associated with infections is irreversible.

    Article  PubMed  Google Scholar 

  58. European Association for the Study of the, L, European Association for the Study of the, L. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53(3):397–417.

    Article  Google Scholar 

  59. Banares R et al. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology. 2013;57(3):1153–62.

    Article  CAS  PubMed  Google Scholar 

  60. Kwo PY. Management of hyponatremia in clinical hepatology practice. Curr Gastroenterol Rep. 2014;16(5):382.

    Article  PubMed  Google Scholar 

  61. Solà E, Graupera I, Ginès P. From refractory ascites to dilutional hyponatremia and hepatorenal syndrome: current options for treatment. Curr Hepatol Rep. 2014;1–9.

  62. Ahluwalia V et al. Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis. J Hepatol. 2013;59(3):467–73.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  63. Gines P, Guevara M. Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management. Hepatology. 2008;48(3):1002–10.

    Article  CAS  PubMed  Google Scholar 

  64. Jalan R et al. Albumin infusion for severe hyponatremia in patients with refractory ascites: a randomized clinical trial. J Hepatol. 2007;46:S95.

    Article  Google Scholar 

  65. Davenport A. Acute renal replacement therapy. In: Harber M, editor. Practical nephrology. London: Springer; 2014. p. 75–90.

    Chapter  Google Scholar 

  66. Asrani SK, O'Leary JG. Acute-on-chronic liver failure. Clin Liver Dis. 2014;18(3):561–74.

    Article  PubMed  Google Scholar 

  67. Jalan R et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol. 2014;60(6):1310–24.

    Article  PubMed  Google Scholar 

  68. Fernandez J et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology. 2012;55(5):1551–61.

    Article  PubMed  Google Scholar 

  69. Montano-Loza AJ. Clinical relevance of sarcopenia in patients with cirrhosis. World J Gastroenterol. 2014;20(25):8061–71.

    Article  PubMed Central  PubMed  Google Scholar 

  70. Butterworth RF. Thiamine deficiency-related brain dysfunction in chronic liver failure. Metab Brain Dis. 2009;24(1):189–96.

    Article  CAS  PubMed  Google Scholar 

  71. Kribben A et al. Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology. 2012;142(4):782–789 e3.

    Article  CAS  PubMed  Google Scholar 

  72. Saliba F et al. Cirrhotic patients in the ICU: prognostic markers and outcome. Curr Opin Crit Care. 2013;19(2):154–60.

    Article  PubMed  Google Scholar 

  73. Cholongitas E et al. Prognostic models in cirrhotics admitted to intensive care units better predict outcome when assessed at 48 h after admission. J Gastroenterol Hepatol. 2008;23(8pt1):1223–7.

    Article  PubMed  Google Scholar 

  74. Moreau R., et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144(7):1426–37. 1437 e1-9. Data from cirrhotics with acute decompensation was utilized to define Acute on chronic liver failure as a distinct entity.

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Sunil Dacha declares no conflict of interest.

Ram M. Subramanian is a consultant for Gambro-Baxter, Inc.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Division of Digestive Diseases, Department of Internal Medicine, Emory University School of Medicine, 615 Michael Street, STE 201, Atlanta, GA, 30329, USA

    Sunil Dacha & Ram M. Subramanian

Authors
  1. Sunil Dacha
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Ram M. Subramanian
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Ram M. Subramanian.

Additional information

This article is part of the Topical Collection on Management of the Cirrhotic Patient

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dacha, S., Subramanian, R.M. Critical Care Management in Cirrhosis. Curr Hepatology Rep 14, 60–68 (2015). https://doi.org/10.1007/s11901-015-0255-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11901-015-0255-9

Keywords